Impact of protease inhibitor therapy on number of cases and costs of dyslipidaemia in HIV-infected patients

被引：0
|
作者：
Richter, A
Irish, W
Lafata, JE
Pladevall, M
McQuay, LJ
Xi, H
Markowitz, N
Brar, I
Manjunath, R
Simpkins, J
Kumar, U
Ramos, MA
Iloeje, UH
机构：
[1] RTI Int, RTI HS, Res Triangle Pk, NC USA
[2] Henry Ford Hlth Syst, Ctr Hlth Serv Res, Detroit, MI USA
[3] Henry Ford Hosp, Div Infect Dis Clin, Detroit, MI 48202 USA
[4] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
72
引用
收藏
页码：L51 / L52
页数：2
相关论文
共 50 条
  • [1] Protease inhibitor therapy in HIV-infected children
    Feingold, AR
    Rutstein, RM
    Meislich, D
    Brown, T
    Rudy, BJ
    AIDS PATIENT CARE AND STDS, 2000, 14 (11) : 589 - 593
  • [2] Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients
    Calza, L
    Manfredi, R
    Chiodo, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 10 - 14
  • [3] Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy
    Dios, PD
    Ocampo, A
    Miralles, C
    Otero, I
    Iglesias, I
    Rayo, N
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1999, 87 (04): : 437 - 441
  • [4] Weight gain associated with protease inhibitor therapy in HIV-infected patients
    Stricker, RB
    Goldberg, B
    RESEARCH IN VIROLOGY, 1998, 149 (02): : 123 - 126
  • [5] Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy
    Martínez, E
    Tuset, M
    Milinkovic, A
    Miró, JM
    Gatell, JM
    ANTIVIRAL THERAPY, 2004, 9 (05) : 649 - 663
  • [6] Darunavir: an effective protease inhibitor for HIV-infected patients
    Phung, Bao-Chau
    Yeni, Patrick
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (06) : 631 - 643
  • [7] Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy
    Vergis, EN
    Paterson, DL
    Wagener, MM
    Swindells, S
    Singh, N
    INTERNATIONAL JOURNAL OF STD & AIDS, 2001, 12 (07) : 463 - 468
  • [8] Dual protease inhibitor therapy in HIV-infected patients: Pharmacologic rationale and clinical benefits
    Flexner, C
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 : 649 - 674
  • [9] Relapsing Visceral Leishmaniasis in HIV-Infected Patients Undergoing Successful Protease Inhibitor Therapy
    J. L. Casado
    R. Lopez-Velez
    V. Pintado
    C. Quereda
    A. Antela
    S. Moreno
    European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 : 202 - 205
  • [10] Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients
    Fatkenheuer, G
    Theisen, A
    Rockstroh, J
    Grabow, T
    Wicke, C
    Becker, K
    Wieland, U
    Pfister, H
    Reiser, M
    Hegener, P
    Franzen, C
    Schwenk, A
    Salzberger, B
    AIDS, 1997, 11 (14) : F113 - F116
12345